Richard A Walsh

Prof. Richard A Walsh


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 April 2024 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
SMSenan Maher
Senan Maher
EDEoghan Donlon
Eoghan Donlon
GMGerard Mullane
Gerard Mullane
RWRichard A Walsh
Richard A Walsh
TLTim Lynch
Tim Lynch
CFConor Fearon
Conor Fearon
Apathy is a prevalent and highly debilitating non-motor symptom of Parkinson’s disease (PD) that is often overlooked in clinical practice due to its subtle nature. This review aims to provide a comprehensive overview of the current evidence for the treatment of apathy in PD, highlighting recent advancements and emerging therapeutic avenues. In this review, we analyse a diverse array of treatment strategies for apathy in PD, including pharmacological interventions, non-pharmacological approaches, and emerging neuromodulation techniques. We evaluate the efficacy, safety, and limitations of established pharmacotherapies, such as dopaminergic agents, antidepressants, and cognitive enhancers. Additionally, we examine the promising role of non-pharmacological interventions, encompassing psychotherapies and behavioural interventions, in ameliorating apathetic symptoms. Furthermore, this review explores the effects of neuromodulation techniques on apathy, including the modulation of apathy via deep brain stimulation and emerging data on the potential influence of transcranial magnetic stimulation (TMS) on apathy in PD. Ultimately, a deeper understanding of effective treatment strategies for apathy has the potential to significantly improve the quality of life and overall well-being of individuals living with PD.

30 June 2025 in Sensors
Verified
Journal Article
Open access
PDF file
MBMaeve Bradley
Maeve Bradley
SOSarah O’loughlin
Sarah O’loughlin
EDEoghan Donlon
Eoghan Donlon
AGAmy Gallagher
Amy Gallagher
COClodagh O'Keeffe
Clodagh O'Keeffe
CFConor Fearon
Conor Fearon
A prior history of falls remains the strongest predictor of future falls in individuals with Parkinson’s disease (PD). There are limited biomarkers available to identify falls risk before falls begin to occur. The aim of this review is to investigate if features associated with falls risk may be detected by wearable sensors in patients with PD. A systematic search of the MEDLINE, EMBASE, Cochrane, and Cinahl databases was performed. Key quality criteria include sample size adequacy, data collection procedures, and the clarity of statistical analyses. The data from each included study were extracted into defined data extraction spreadsheets. Results were synthesized in a narrative manner. Twenty-four articles met the inclusion criteria. Of these, twelve measured falls prospectively, while the remaining relied on retrospective history. The definition of a “faller” varied across studies. Most assessments were conducted in a clinical setting (18/24). There was considerable variability in sensor placement and mobility tasks assessed. The most common sensor-derived measures that significantly differentiated “fallers” from “non-fallers” in Parkinson’s disease included gait variability, stride variability, trunk motion, walking speed, and stride length.

17 January 2022 in Tremor and Other Hyperkinetic Movements
Verified
Journal Article
Open access
PDF file
EDEoghan Donlon
Eoghan Donlon
PMPat Moloney
Pat Moloney
DFDarragh Frier
Darragh Frier
RMRobert McFarlane
Robert McFarlane
SSShane Smyth
Shane Smyth
EMEavan McGovern
Eavan McGovern
Though uncommon, primary movement disorders can occur in pregnancy, the most common being restless legs syndrome and chorea gravidarum [1]. New onset dystonia in pregnancy has been reported four times previously with a resolution of symptoms within six months of delivery [2345]. Exacerbation of pre-existing movement disorders and the onset of de novo movement disorders during pregnancy support the hypothesis that female sex hormones play an important role in the regulation of basal ganglia circuitry. Here we describe a case of new-onset cervical dystonia during pregnancy with persistence of symptoms after delivery. The phenotypic overlap between this case and previously reported cases further establishes dystonia gravidarum as a distinct clinical entity.